NT5E and triple-negative breast carcinoma: The cell surface expression of PD-L1 and/or CD73 on triple-negative breast cancer cells enables anergy or apoptosis of effector T cells with a concomitant increase in regulatory T cells in the tumour microenvironment, thus impairing adaptive antitumour immunity [25].